Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.9 USD | +2.18% | +1.71% | +75.20% |
Business Summary
Number of employees: 49
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Radiotherapies
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sandesh Seth
CEO | Chief Executive Officer | 60 | 01/12/01 |
Steve O'Loughlin
DFI | Director of Finance/CFO | 39 | 13/15/13 |
Monideepa Roy
CTO | Chief Tech/Sci/R&D Officer | - | 27/21/27 |
Mary Mei Chen
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Avinash Desai
CTO | Chief Tech/Sci/R&D Officer | - | 19/20/19 |
Stephen Dressel
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - | |
Jenny Hsieh
PRN | Corporate Officer/Principal | - | - |
Paul Diamond
LAW | General Counsel | - | 01/21/01 |
Gary Siegel
AUD | Comptroller/Controller/Auditor | 66 | 01/17/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 08/13/08 | |
C. Nicholson
BRD | Director/Board Member | 68 | 01/08/01 |
Ajit Shetty
BRD | Director/Board Member | 77 | 28/17/28 |
Sandesh Seth
CEO | Chief Executive Officer | 60 | 01/12/01 |
Jeffrey Chell
BRD | Director/Board Member | 70 | 01/18/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,783,451 | 29,147,811 ( 97.87 %) | 0 | 97.87 % |
Company contact information
Actinium Pharmaceuticals, Inc.
100 Park Avenue 23rd floor
10017, New York
+646 677 3870
http://www.actiniumpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+75.20% | 265M | |
+2.97% | 108B | |
+10.21% | 104B | |
+1.57% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- ATNM Stock
- Company Actinium Pharmaceuticals, Inc.